Clinical trials
Phase 1/2 Leukemia, Myeloid, Acute trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 10 |
| Terminated | 8 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Fred Hutchinson Cancer Center | 3 |
| Novartis Pharmaceuticals | 3 |
| Astellas Pharma Global Development, Inc. | 2 |
| Technische Universität Dresden | 2 |
| University of Ulm | 2 |
| Advesya SAS | 1 |
| Aptose Biosciences Inc. | 1 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 49 |
| Myelodysplastic Syndromes | 14 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 |
| Recurrence | 10 |
| Leukemia | 6 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Hodgkin Disease | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Multiple Myeloma | 3 |
| Myeloproliferative Disorders | 3 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.